Concepedia

Michael Wohlfeiler

MW

Statistics

Publications

16

Citations

1.4K

H-Index

14

Active since

1999

Affiliations

AIDS Healthcare Foundation(Current)

ViiV Healthcare (United Kingdom)

Merck & Co., Inc., Rahway, NJ, USA (United States)

NYU Langone Health

University College Dublin

Michael Wohlfeiler is an author at AIDS Healthcare Foundation specializing in pharmacotherapy, clinical pharmacology, and antiretroviral therapy.

Publications per year

1999–2023

16

Publications

16

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 741 citations · Full text

, , +17

Weight gain before and after switch from TDF to TAF in a U.S. cohort study

Patrick Mallon, Laurence Brunet, Ricky K Hsu et al. · Journal of the International AIDS Society · 2021 · 131 citations · Full text

, , +14

STD Screening of HIV-Infected MSM in HIV Clinics

Karen W. Hoover, Mary Butler, Kimberly Workowski et al. · Sexually Transmitted Diseases · 2010 · 108 citations

, , +17

Treatment of Mucocutaneous Herpes Simplex Virus Infections Unresponsive to Acyclovir With Topical Foscarnet Cream in AIDS Patients: A Phase I/II Study

Kedarnath Javaly, Michael Wohlfeiler, Robert C. Kalayjian et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 1999 · 54 citations

, , +14

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort

Michael Sension, Laurence Brunet, Ricky K Hsu et al. · Infectious Diseases and Therapy · 2023 · 53 citations · Full text

, , +16

1–5 of 16